Hemi-diaphragmatic Paresis After Erector Spinae Plane Block
Hemi-diaphragmatic Paresis After Ultrasound-guided Erector Spinae Plane Block in Carotid Endarterectomy
Sponsors |
Lead Sponsor: Antalya Training and Research Hospital |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Source | Antalya Training and Research Hospital | ||||||||||
Brief Summary | To assess the incidence of hemi-diaphragmatic paresis following ultrasound-guided erector spinae plane (ESP) block |
||||||||||
Detailed Description | The ultrasound (USG) guided ESP block was first defined in 2016. With the administration of local anesthesia between the transverse process of the vertebra and the erector spinae muscle, it is stated that the effect mechanism of ESP is that spread blocks the ventral and dorsal rami to the paravertebral area. The aim of the study is to assess the incidence of hemi-diaphragmatic paresis following ultrasound-guided erector spinae plane block. |
||||||||||
Overall Status | Recruiting | ||||||||||
Start Date | January 20, 2021 | ||||||||||
Completion Date | April 30, 2021 | ||||||||||
Primary Completion Date | April 30, 2021 | ||||||||||
Study Type | Observational [Patient Registry] | ||||||||||
Primary Outcome |
|
||||||||||
Secondary Outcome |
|
||||||||||
Enrollment | 20 | ||||||||||
Condition | |||||||||||
Intervention |
Intervention Type: Other Intervention Name: ESP block Description: ESP block performed using ultrasound guidance. Diaphragmatic excursion was measured using M-mode ultrasound during normal breathing, deep breathing and with the sniff manoeuvre. Arm Group Label: ESP block group |
||||||||||
Eligibility |
Sampling Method: Probability Sample
Criteria:
Inclusion Criteria: - 18 - 85 years - American Society of Anesthesiology (ASA) I-III - elective carotid endarterectomy Exclusion Criteria: - patient's refusal - under 18 years of age or over 65 years of age - ASA IV and above - known allergy to local anaesthetic drugs - the block cannot be applied due to bleeding disorders or localized skin infection at the injection site - history of neurological and/or neuromucular disease - history of severe bronchopulmonary disease - a moderate to severe decrease in preoperative pulmonary function, or abnormality in preoperative chest radiography data (pleural effusion, pneumothorax, or hemidiaphragm elevation) - emergency surgery Gender: All Minimum Age: 18 Years Maximum Age: 85 Years Healthy Volunteers: No |
||||||||||
Overall Official |
|
||||||||||
Overall Contact |
Last Name: Arzu Karaveli Phone: +905325611300 Email: [email protected] |
||||||||||
Location |
|
||||||||||
Location Countries |
Turkey |
||||||||||
Verification Date |
January 2021 |
||||||||||
Responsible Party |
Type: Sponsor |
||||||||||
Keywords | |||||||||||
Has Expanded Access | No | ||||||||||
Condition Browse | |||||||||||
Arm Group |
Label: ESP block group Description: Diaphragmatic excursion was measured using M-mode ultrasound during normal breathing, deep breathing and with the sniff manoeuvre. |
||||||||||
Patient Data | No | ||||||||||
Study Design Info |
Observational Model: Case-Only Time Perspective: Prospective |